Ryan Bethencourt

Ryan Bethencourt joined PAREXEL Early Phase in 2008 as Director of Business Development with responsibilities for managing business and corporate development functions and establishing strategic clinical collaborations on the West Coast and with Key Accounts in the NorthEast US. Prior to joining CCT/Parexel, Ryan was with Quintiles, Inc where he served as Manager of European Business Development for Phase I/II Clinical Development Programs, based in London, England. During his time with Quintiles he worked in partnership with most major Pharmaceutical and emerging Biotech companies to successfully conduct a broad range of early clinical development studies. Earlier in his career, Ryan worked in a variety of sales and business development roles within Pfizer, Merck and Cephalon. Ryan received a Master’s in Bioscience Enterprise (an MBA/Biotech fusion course) from the University of Cambridge and a BS degree in Biology and Genetics from the University of Warwick. Ryan is also a published author in the field of Biotechnology Business Development and is involved with start-up Biotech ventures.

Previous speaker at:

- Humanity + Caltech conference (2010) - talk titled "2020 the Future of the Biopharmaceutical industry "

- BIL conference 2011, Long Beach, Ca, talked titled "DIY Bio and the future of the Biopharmaceutical industry"


Rawflow.com (2001) - VC funded by Benchmark Capital £2M

Genescient Pharma division (2010)- Adviser and former P/T COO

Open Industrial (2011) - Open source DIY Scientific Equipment provider